tetano
Editor, Senior Moderator
SAGE Open Med Case Rep
. 2023 Dec 20:11:2050313X231220803.
doi: 10.1177/2050313X231220803. eCollection 2023. Cardiac arrest in the setting of probable catastrophic antiphospholipid syndrome in young patient with a history of COVID infection and polyglandular disorder-Case report
Seyed M Nahidi[SUP] 1 [/SUP], Yash Garg[SUP] 1 [/SUP], Devi S Mahadeo[SUP] 2 [/SUP], Manjari Sharma[SUP] 1 [/SUP], Cesar Acosta[SUP] 1 [/SUP], Karthik Seetharam[SUP] 1 [/SUP], Mukosolu F Obi[SUP] 1 [/SUP]
Affiliations
Antiphospholipid syndrome is an autoimmune disorder characterized by arterial and venous thrombosis and recurrent spontaneous abortions due to the persistent presence of antiphospholipid antibodies. Probable Catastrophic antiphospholipid (Catastrophic antiphospholipid-like syndrome) is a life-threatening presentation of antiphospholipid syndrome which manifests as intravascular thrombosis, leading to rapid onset of symptoms and involvement of multiple organ systems. We present a case of a 28-year-old woman with a history of polyglandular autoimmune syndrome, systemic lupus erythematosus, provoked bilateral deep vein thrombosis in the setting of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection 2 years prior, and hypothyroidism who presents with a cardiac arrest in the setting of an acute ST-elevation myocardial infarction with thromboembolic occlusion of two coronary arteries simultaneously in the setting of noncompliance with anticoagulation for the past 1 week. Her presentation was further complicated by acute hypoxic respiratory failure due to diffuse alveolar hemorrhage during the hospital course with progressive multiorgan failure and eventual death. Catastrophic antiphospholipid is associated with high morbidity and mortality, thus a timely diagnosis and multidisciplinary approach to management is needed for evaluation and management.
Keywords: Cardiac arrest; antiphospholipid syndrome; catastrophic antiphospholipid syndrome; myocardial infarction.
. 2023 Dec 20:11:2050313X231220803.
doi: 10.1177/2050313X231220803. eCollection 2023. Cardiac arrest in the setting of probable catastrophic antiphospholipid syndrome in young patient with a history of COVID infection and polyglandular disorder-Case report
Seyed M Nahidi[SUP] 1 [/SUP], Yash Garg[SUP] 1 [/SUP], Devi S Mahadeo[SUP] 2 [/SUP], Manjari Sharma[SUP] 1 [/SUP], Cesar Acosta[SUP] 1 [/SUP], Karthik Seetharam[SUP] 1 [/SUP], Mukosolu F Obi[SUP] 1 [/SUP]
Affiliations
- PMID: 38130915
- PMCID: PMC10734326
- DOI: 10.1177/2050313X231220803
Antiphospholipid syndrome is an autoimmune disorder characterized by arterial and venous thrombosis and recurrent spontaneous abortions due to the persistent presence of antiphospholipid antibodies. Probable Catastrophic antiphospholipid (Catastrophic antiphospholipid-like syndrome) is a life-threatening presentation of antiphospholipid syndrome which manifests as intravascular thrombosis, leading to rapid onset of symptoms and involvement of multiple organ systems. We present a case of a 28-year-old woman with a history of polyglandular autoimmune syndrome, systemic lupus erythematosus, provoked bilateral deep vein thrombosis in the setting of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection 2 years prior, and hypothyroidism who presents with a cardiac arrest in the setting of an acute ST-elevation myocardial infarction with thromboembolic occlusion of two coronary arteries simultaneously in the setting of noncompliance with anticoagulation for the past 1 week. Her presentation was further complicated by acute hypoxic respiratory failure due to diffuse alveolar hemorrhage during the hospital course with progressive multiorgan failure and eventual death. Catastrophic antiphospholipid is associated with high morbidity and mortality, thus a timely diagnosis and multidisciplinary approach to management is needed for evaluation and management.
Keywords: Cardiac arrest; antiphospholipid syndrome; catastrophic antiphospholipid syndrome; myocardial infarction.